A Study of Zetomipzomib (KZR-616) in Patients With Active Lupus Nephritis (PALIZADE) (clinicaltrials.gov) - Oct 4, 2024 - P2 | N=279 | Suspended | Sponsor: Kezar Life Sciences, Inc. | Recruiting ➔ Suspended
Trial suspension • Glomerulonephritis • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology
|